- Home
- PBYI vs AEYE Comparison
PBYI vs AEYE Comparison
Compare PBYI & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- AEYE
- Stock Information
- Founded
- PBYI 2010
- AEYE 2005
- Country
- PBYI United States
- AEYE United States
- Employees
- PBYI N/A
- AEYE N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- AEYE Computer Software: Prepackaged Software
- Sector
- PBYI Health Care
- AEYE Technology
- Exchange
- PBYI Nasdaq
- AEYE Nasdaq
- Market Cap
- PBYI 138.4M
- AEYE 153.6M
- IPO Year
- PBYI N/A
- AEYE N/A
- Fundamental
- Price
- PBYI $2.86
- AEYE $11.30
- Analyst Decision
- PBYI Strong Buy
- AEYE Strong Buy
- Analyst Count
- PBYI 1
- AEYE 5
- Target Price
- PBYI $7.00
- AEYE $26.10
- AVG Volume (30 Days)
- PBYI 334.3K
- AEYE 141.0K
- Earning Date
- PBYI 05-01-2025
- AEYE 04-29-2025
- Dividend Yield
- PBYI N/A
- AEYE N/A
- EPS Growth
- PBYI 37.78
- AEYE N/A
- EPS
- PBYI 0.62
- AEYE N/A
- Revenue
- PBYI $230,468,000.00
- AEYE $35,201,000.00
- Revenue This Year
- PBYI N/A
- AEYE $20.29
- Revenue Next Year
- PBYI N/A
- AEYE $18.65
- P/E Ratio
- PBYI $4.61
- AEYE N/A
- Revenue Growth
- PBYI N/A
- AEYE 12.41
- 52 Week Low
- PBYI $2.23
- AEYE $8.91
- 52 Week High
- PBYI $5.34
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- PBYI 42.27
- AEYE 46.68
- Support Level
- PBYI $2.83
- AEYE $8.91
- Resistance Level
- PBYI $2.99
- AEYE $11.96
- Average True Range (ATR)
- PBYI 0.17
- AEYE 1.00
- MACD
- PBYI -0.01
- AEYE 0.21
- Stochastic Oscillator
- PBYI 50.00
- AEYE 78.36
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.